Peripheral (BTK) Solution
Below-the-Knee Peripheral Artery Disease
Key Facts
About Vantis Vascular
Vantis Vascular is a clinical-stage medical device innovator targeting the high-growth market for complex vascular interventions. The company's core technology is the CrossFast™ system, a dual-catheter delivery platform engineered to navigate challenging anatomies, with the potential to reduce complications and increase procedural efficiency. Founded by physicians, Vantis is leveraging its platform to develop next-generation solutions, including an intravascular lithotripsy (IVL) system and specialized peripheral (BTK) devices. With a seasoned leadership team experienced in vascular device startups and exits, the company is positioned to address significant unmet needs in interventional cardiology and vascular medicine.
View full company profileTherapeutic Areas
Other Below-the-Knee Peripheral Artery Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| MOTIV Bioresorbable Scaffold | REVA Medical | Pre-market Approval (FDA Breakthrough) |
| Virtue® SAB | Orchestra BioMed | Investigational |